BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10932298)

  • 21. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thymus CT scan and thymoma associated antibodies in myasthenia gravis with thymoma].
    Li YF; Li YH; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):517-9. PubMed ID: 16995304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy.
    Heidenreich F; Vincent A
    Neurology; 1998 May; 50(5):1483-5. PubMed ID: 9596015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance.
    Aarli JA; Skeie GO; Mygland A; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():505-15. PubMed ID: 9668283
    [No Abstract]   [Full Text] [Related]  

  • 25. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 27. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antirapsyn antibodies occur commonly in patients with lupus.
    Agius MA; Zhu S; Aarli JA
    Ann N Y Acad Sci; 1998 May; 841():525-6. PubMed ID: 9668286
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF.
    Bogousslavsky J; Regli F; Doret AM; Fulpius BW; Ostinelli B; Rabinowicz T; Ruzicka J
    Eur Neurol; 1983; 22(5):301-6. PubMed ID: 6628458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant thymoma and myasthenia gravis presenting as polymyositis: a case report.
    Lee AB; Thurston RS
    J La State Med Soc; 2008; 160(5):286-8. PubMed ID: 19048985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: Cause of weakness in myasthenia gravis.
    Grob D
    N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544
    [No Abstract]   [Full Text] [Related]  

  • 34. Myasthenia gravis and autoantibodies.
    Nishitani H
    Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
    [No Abstract]   [Full Text] [Related]  

  • 35. Devic disease and thymoma with anti-central nervous system and antithymus antibodies.
    Antoine JC; Camdessanché JP; Absi L; Lassablière F; Féasson L
    Neurology; 2004 Mar; 62(6):978-80. PubMed ID: 15037705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of myasthenia].
    Depieds H
    Ann Chir; 1971 May; 25(9):524-5. PubMed ID: 5557369
    [No Abstract]   [Full Text] [Related]  

  • 37. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
    Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
    Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibodies to DNA in myasthenia].
    Saprygin DB; Gekht BM; Kolomenskaia EA; Perel'man LB; Poverennyi AM
    Biull Eksp Biol Med; 1969 May; 67(5):50-2. PubMed ID: 5379165
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis.
    Suzuki S; Nishimoto T; Kohno M; Utsugisawa K; Nagane Y; Kuwana M; Suzuki N
    J Neuroimmunol; 2013 May; 258(1-2):61-6. PubMed ID: 23561592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
    Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
    Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.